On January 17, the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) jointly published two final ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

The New York State health department is underscoring the importance of addiction medication in ending the opioid crisis.

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use ...

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The program is being launched with the help of money awarded to Kentucky in settlements with pharmacies that helped fuel the ...

Rutgers Health, in partnership with the New Jersey Department of Labor and Workforce Development (NJDOL), has launched the ...

Acadia Healthcare Co. Inc. will again face a whistleblower’s False Claims Act suit alleging that the company improperly billed federal health-care programs for treatment related to opioid use disorder ...

A study on rats found that administering 2,5-dimethoxy-4-iodoamphetamine before giving them an opportunity to take heroin ...

The Delaware Prescription Opioid Settlement Commission has a new co-chair.

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...